background
clinic
diagnosi
japanes
enceph
usual
difficult
due
nonspecif
sign
earli
acut
stage
infect
viru
isol
peripher
blood
also
possibl
short
period
low
level
transient
viremia
even
acut
stage
diseas
thu
urgent
develop
feasibl
conveni
method
laboratori
diagnosi
infect
object
establish
newli
design
molecular
approach
use
detect
intracellular
japanes
enceph
viral
rna
host
cell
studi
design
method
firstli
establish
carri
test
efficaci
cultur
cell
subsequ
peripher
blood
mononuclear
cell
pbmc
isol
mice
inocul
je
viru
suspens
result
studi
situ
reversetranscript
loopmedi
isotherm
amplif
situ
rtlamp
establish
combin
merit
recent
develop
loopmedi
isotherm
amplif
lamp
situ
reversetranscriptas
polymeras
chain
reaction
situ
rtpcr
conclus
newli
design
method
detect
viral
rna
peripher
blood
mononuclear
cell
pbmc
short
time
high
sensit
effici
wj
chen
author
contribut
equal
studi
japanes
enceph
je
one
import
mosquitoborn
viral
infecti
diseas
world
infect
approxim
suscept
popul
southeast
asian
countri
year
etiolog
agent
je
belong
famili
flavivirida
also
includ
mani
relat
virus
yellow
fever
viru
dengu
virus
west
nile
viru
genom
je
viru
compos
posit
singlestrand
rna
approxim
base
length
infect
rate
je
viru
epidem
region
usual
vari
rang
case
popul
clinic
least
case
death
occur
year
mostli
among
children
asia
spite
mass
vaccin
implement
mani
endem
countri
diagnosi
je
clinic
symptom
feasibl
due
nonspecif
sign
earli
acut
stage
infect
neither
possibl
isol
je
viru
peripher
blood
short
period
low
level
transient
viremia
even
acut
stage
diseas
nowaday
laboratori
serodiagnosi
je
use
versatil
conveni
approach
detect
immunoglobulin
igm
igg
antibodi
serum
cerebrospin
fluid
csf
enzymelink
immunosorb
assay
elisa
recent
molecular
techniqu
eg
reversetranscriptas
polymeras
chain
reaction
rtpcr
amplifi
gene
fragment
viral
rna
increasingli
use
make
diagnos
nevertheless
low
copi
number
viral
rna
blood
je
patient
make
difficult
extract
rna
sourc
util
rtpcr
detect
viral
rna
peripher
blood
mononuclear
cell
pbmc
also
call
situ
rtpcr
thu
develop
molecular
tool
requir
messeng
rna
extract
techniqu
appli
diagnos
je
viru
infect
pbmc
mous
model
techniqu
loopmedi
isotherm
amplif
lamp
base
principl
strand
displac
reaction
stemloop
structur
amplifi
target
gene
fragment
isotherm
condit
target
initi
recogn
six
distinct
sequenc
follow
anoth
four
distinct
sequenc
amplif
target
sequenc
expect
highli
select
furthermor
need
highcost
instrument
thermocycl
gel
imag
system
make
techniqu
reliabl
simpl
rapid
costeffect
detect
differenti
examin
genom
nucleic
acid
studi
aim
establish
new
approach
name
situ
reversetranscript
loopmedi
isotherm
amplif
situ
rtlamp
order
detect
je
viru
infect
cultur
cell
pbmc
isol
infect
mice
establish
approach
combin
techniqu
rtlamp
situ
rtpcr
previous
describ
laboratori
je
viru
use
studi
strain
previous
isol
fieldcaught
armiger
subalbatu
viru
propag
cell
titrat
cell
base
previou
report
cell
maintain
laboratori
c
co
minimum
essenti
medium
gibco
tm
brl
life
technolog
grand
island
ny
usa
contain
nonessenti
amino
acid
gml
sodium
bicarbon
nahco
antibioticantimycot
fetal
bovin
serum
plaqu
assay
follow
previou
descript
use
viru
titrat
studi
viru
titer
calcul
express
plaqueform
unit
per
millilit
pfuml
oligonucleotid
primer
use
rtlamp
amplif
use
studi
design
prm
gene
je
viru
sequenc
strain
retriev
genbank
databas
access
set
six
primer
compris
two
outer
two
inner
fip
bip
two
loop
primer
lf
lp
select
base
criteria
shown
previou
descript
fip
consist
complementari
sequenc
sens
sequenc
bip
consist
complementari
sequenc
sens
sequenc
two
loop
primer
design
acceler
amplif
reaction
lf
lb
primer
compos
sequenc
complementari
sequenc
region
respect
detail
primer
regard
posit
genom
sequenc
shown
tabl
genom
viral
rna
je
viru
extract
infect
cultur
supernat
use
viral
nucleic
acid
extract
kit
ii
geneaid
biotech
taipei
taiwan
accord
manufactur
protocol
total
rna
extract
je
virusinfect
cell
standard
trizol
gibcobrl
life
technolog
chloroformisopropylethanol
wash
method
use
describ
previous
studi
rtpcr
use
compar
rtlamp
assay
describ
primer
pair
use
amplifi
specif
genom
fragment
nt
je
viru
cover
noncod
region
c
prm
gene
sequenc
sens
primer
complementari
primer
respect
studi
rt
perform
bip
primer
c
min
lamp
reaction
carri
total
reaction
mixtur
contain
l
cdna
mixtur
studi
cell
infect
strain
je
viru
h
multipl
infect
moi
transfer
flask
microtub
cell
fix
paraformaldehyd
min
permeabil
triton
min
c
situ
reaction
rt
cell
precipit
centrifug
g
remov
rt
reaction
mixtur
cell
resuspend
lamp
reaction
mixtur
lamp
reaction
perform
mention
follow
step
cell
treat
block
solut
bovin
serum
albumin
bsa
min
order
visual
target
cdna
insid
cell
ad
digoxigenin
dig
label
primer
end
inner
fip
primer
label
dig
mm
diglabel
dctp
lamp
reaction
cell
wash
phosphatebuff
salin
pb
l
dilut
goat
antidig
antibodi
conjug
alkalin
phosphatas
roch
mannheim
germani
pb
ad
microtub
incub
subsequ
cell
wash
twice
wash
solut
contain
mm
maleic
acid
mm
nacl
ph
min
follow
wash
solut
mm
trishcl
mm
nacl
mm
mgcl
ph
subsequ
substrat
nitroblu
tetrazolium
nbtbcip
ad
microtub
incub
min
cell
wash
pb
remov
tube
distribut
onto
slide
studi
femal
icr
mous
intraven
inject
l
pb
control
group
pfu
je
viru
suspens
pbmc
isol
ml
whole
blood
taken
postinocul
pool
seven
eight
inocul
mice
ficollhypaqu
solut
ge
healthcar
bioscienc
uppsala
sweden
diglabel
primer
dctp
use
studi
visual
amplifi
gene
fragment
rtlamp
carri
method
southern
blot
briefli
aliquot
rtlamp
product
first
run
electrophoresi
agaros
gel
tae
buffer
gel
treat
denatur
solut
nacl
n
naoh
twice
min
neutral
solut
trishcl
nacl
min
transfer
onto
nylon
membran
membran
expos
uv
min
crosslink
spectrolink
uv
crosslink
membran
immers
block
solut
bsa
mm
maleic
acid
mm
nacl
ph
autoclav
min
incub
antidigap
antibodi
block
solut
min
ultim
solut
contain
nbtbcip
substrat
color
could
visual
success
rtlamp
method
reli
specif
design
primer
set
primer
select
target
prm
gene
deriv
strain
je
viru
order
valid
sensit
specif
primer
set
g
total
rna
extract
je
virusor
mockinfect
cell
separ
subject
rtlamp
reaction
c
min
rt
subsequ
c
min
lamp
reaction
meantim
rtpcr
use
experi
posit
control
result
indic
viral
rna
could
detect
extract
je
virusinfect
cell
mockinfect
cell
concentr
shown
dna
ladderlik
product
fig
rtpcr
viral
rna
also
detect
show
singl
band
repres
fragment
fig
examin
limit
reaction
time
lamp
perform
interv
min
viral
gene
detect
earli
min
time
cours
min
amplif
shown
optim
condit
fig
studi
diglabel
use
better
visual
reaction
situ
rtlamp
run
diglabel
primer
amplifi
dna
ladderlik
product
clearli
detect
group
use
unlabel
diglabel
primer
although
signal
use
latter
primer
rel
weak
fig
howev
signal
appear
nylon
membran
amplifi
dna
fragment
transfer
indic
dig
molecul
incorpor
amplifi
fragment
fig
hand
use
situ
rtlamp
diglabel
dctp
dna
ladderlik
amplifi
product
shown
unlabel
group
two
group
label
dctp
mm
mockinfect
cell
fig
rtlamp
product
transfer
onto
nylon
membran
visual
relev
antibodi
substrat
mention
dna
ladder
actual
present
membran
dosedepend
manner
fig
situ
rtlamp
run
diglabel
primer
posit
reaction
shown
either
je
virusinfect
fig
uninfect
fig
cell
howev
posit
reaction
deepbrown
color
obviou
je
virusinfect
cell
fig
uninfect
cell
fig
reaction
run
diglabel
dctp
use
diglabel
dctp
result
show
je
viru
detect
pbmc
isol
mice
inoc
ulat
viru
suspens
fig
mockinocul
mice
fig
addit
result
reveal
highest
infect
rate
pbmc
occur
postinocul
rel
low
rate
pbmc
shown
postinocul
fig
known
pathogenesi
je
reveal
viru
enter
pbmc
includ
monocytesmacrophag
primari
site
replic
vertebr
host
subsequ
viru
migrat
central
nervou
system
cn
brain
inflamm
enceph
may
occur
je
fatal
fatal
rate
infect
statist
differ
differ
local
recov
infect
clinic
symptom
often
display
sequela
seriou
neurolog
impair
andor
mental
retard
result
rapid
effici
techniqu
earli
diagnosi
je
urgent
critic
need
past
year
viru
isol
nerv
tissu
antibodi
igm
igg
detect
serum
andor
csf
extens
use
detect
je
viru
laboratori
howev
molecular
techniqu
includ
rtpcr
realtim
rtpcr
assay
believ
use
due
characterist
rapid
high
sensit
high
specif
techniqu
routin
use
identifi
je
viru
acutephas
serum
csf
sampl
patient
drawback
molecular
techniqu
actual
includ
requir
delic
labor
experienc
techniqu
well
rel
expens
instrument
result
restrict
applic
number
laboratori
develop
countri
variou
gene
fragmentamplif
techniqu
rtpcr
realtim
rtpcr
taqman
sybr
green
nucleic
acid
sequencebas
amplif
nasba
develop
past
decad
goal
rapidli
identifi
je
viru
greater
accuraci
despit
high
magnitud
amplif
pcrbase
method
requir
either
highprecis
instrument
amplif
elabor
method
detect
amplifi
product
meantim
method
often
cumbersom
adapt
routin
clinic
use
develop
lamp
techniqu
new
era
rapid
effici
identif
microbi
infect
initi
particularli
use
reaction
monitor
realtim
detect
chang
turbid
moreov
high
sensit
specif
facilit
potenti
use
laboratori
diagnosi
number
infect
cover
kind
organ
thu
far
techniqu
appli
detect
identifi
virus
fungi
bacteria
protozoa
even
vertebr
recent
techniqu
rtlamp
modifi
convent
lamp
specif
use
effici
rapidli
detect
identifi
variou
rna
virus
includ
flavivirus
togavirus
sever
acut
respiratori
syndrom
sar
coronaviru
avian
influenza
viru
applic
rtlamp
je
viru
detect
shown
rel
rapid
allow
viru
quantif
demonstr
techniqu
use
rapid
diagnosi
je
use
acutephas
csf
sampl
epidem
spite
rtlamp
detect
je
viru
rapid
quantit
approach
requir
larger
number
serum
csf
specimen
achiev
clinic
diagnosi
je
patient
note
je
viru
persist
mice
week
follow
intraperiton
inocul
may
later
reactiv
addit
je
viru
also
report
persist
nervou
system
patient
matter
fact
flavivirus
includ
je
viru
flavivirus
identifi
exist
pbmc
convalesc
blood
sampl
indic
possibl
persist
viral
infect
leukocyt
moreov
je
viral
rna
fragment
ever
amplifi
white
blood
cell
acut
phase
infect
suggest
detect
virus
leukocyt
may
help
make
diagnosi
even
though
blood
collect
acut
viremia
stage
order
achiev
goal
herein
establish
techniqu
call
situ
rtlamp
success
appli
detect
je
viru
cultur
cell
pbmc
isol
infect
mice
techniqu
situ
rtlamp
avoid
drawback
potenti
ineffici
rna
extract
necessari
step
convent
rtpcr
well
rtlamp
furthermor
one
advantag
experi
run
constant
temperatur
thu
need
thermocycl
necessari
run
techniqu
convent
rtpcr
although
situ
rtpcr
actual
skip
process
rna
extract
still
need
expens
instrument
thermocycl
word
situ
rtlamp
actual
conveni
situ
rtpcr
lamp
build
highereffici
protocol
initi
carri
diglabel
primer
howev
satisfactori
signal
shown
either
gel
electrophoresi
blot
nc
membran
experi
use
infect
cell
suggest
larg
size
dig
molecul
label
outer
primer
fip
probabl
interrupt
bind
stemloop
dna
thu
shift
diglabel
dctp
turn
amplif
nucleic
acid
success
detect
could
clearli
differenti
control
group
mockinfect
indic
diglabel
dctp
rel
effici
compar
primer
label
much
effici
result
better
visual
easier
differenti
neg
result
addit
detect
je
viru
cultur
cell
techniqu
also
appli
detect
viru
pbmc
isol
whole
blood
infect
mice
eventu
viru
detect
postinocul
consist
previou
work
use
situ
rtpcr
nearli
half
inocul
mice
die
diseas
data
shown
suggest
infect
pbmc
may
migrat
brain
tissu
taken
togeth
newli
design
techniqu
situ
rtlamp
sensit
higher
detect
rate
rapid
h
effici
isotherm
condit
cheap
need
expens
instrument
conveni
laborintens
method
new
diagnost
design
serv
robust
tool
diagnos
je
viru
infect
especi
remot
develop
countri
particularli
use
detect
virus
blood
sampl
usual
genom
copi
number
low
collect
acut
stage
persist
infect
theoret
delic
techniqu
also
appli
diagnos
virus
normal
infect
leukocyt
pbmc
eg
human
immunodefici
viru
hiv
advantag
economi
conveni
high
effici
would
like
declar
financi
person
relationship
peopl
organ
could
inappropri
influenc
work
submiss
process
